Cadila slumps after Citi downgrade

Tags: Companies
Shares of Cadila Healthcare fall around 10 percent after Citigroup downgrades them to "sell" from "buy".

Citi says Cadila's valuations "have moved well ahead of fundamentals," despite gradual recovery in the sector and improving US business.

Prefers Aurobindo Pharma and Glenmark Pharmaceuticals in midcaps among drugmakers.

EDITORIAL OF THE DAY

  • RBI must now educate investors on the benefits of debt market

    It is uncommon for the central bank to act on a policy decision within a week of submission of a specialist report.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Urs Schoettli

Japan needs more women in high office

Japan does not rank high in international tables, when it ...

Kuruvilla Pandikattu

Giving up faith is a complex act

We have met many people who have given up religion ...

Shona Adhikari

Belated recognition of women in America's modern art movement

This week we focus on a very important exhibition that ...